fda bpc 157 warning unapproved drug panel narrowly backs peptide drugs – NBC4 Washington Advisers to the FDA back

Advisers to the FDA back broad access to unapproved peptides, despite agency concerns An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link A closer look at the unapproved peptide injections News, Sports, Jobs Times Observer

SKU: 42556090193 · From iglepidom.org